Literature DB >> 29058545

MicroRNAs in the Diagnosis and Treatment of Cancer.

Behzad Mansoori1,2, Ali Mohammadi1,2, Solmaz Shirjang1, Behzad Baradaran1.   

Abstract

Immune cells are recruited into the tumor microenvironment and regulate anti- and pro-tumor signals. MicroRNAs (miRNAs) markedly control the immune system responses in cancer development. miRNAs that affect the immune system could be interesting targets for immunomodulation against cancer, either through the activation of effector cells or through the down-regulation of regulatory cells. Bioinformatic calculations can predict the immune system and miRNA interactions. In this review, we discuss the most recent studies about miRNA as the main regulator of recruitment and the activation of the immune system in the tumor microenvironment and finally we propose several miRNAs that could serve as therapeutic molecules in the immunotherapy of cancer.

Entities:  

Keywords:  MicroRNA; cancer; immune response; immunomodulation; immunotherapy

Mesh:

Substances:

Year:  2017        PMID: 29058545     DOI: 10.1080/08820139.2017.1377407

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  17 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Genes involved in miRNA biogenesis affect meiosis and fertility.

Authors:  Mónica Pradillo; Juan L Santos
Journal:  Chromosome Res       Date:  2018-10-20       Impact factor: 5.239

Review 3.  Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes.

Authors:  Marta Magdalena Fudalej; Anna Maria Badowska-Kozakiewicz
Journal:  Oncol Lett       Date:  2021-03-28       Impact factor: 2.967

Review 4.  Mechanisms of vascular comorbidity in autoimmune diseases.

Authors:  György Nagy; Nóra Németh; Edit I Buzás
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

Review 5.  Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins?

Authors:  Lucie Coppin; Julie Leclerc; Audrey Vincent; Nicole Porchet; Pascal Pigny
Journal:  Int J Mol Sci       Date:  2018-02-25       Impact factor: 5.923

Review 6.  Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death.

Authors:  Zahra Asadzadeh; Elham Safarzadeh; Sahar Safaei; Ali Baradaran; Ali Mohammadi; Khalil Hajiasgharzadeh; Afshin Derakhshani; Antonella Argentiero; Nicola Silvestris; Behzad Baradaran
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

7.  Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.

Authors:  Thilde Terkelsen; Francesco Russo; Pavel Gromov; Vilde Drageset Haakensen; Søren Brunak; Irina Gromova; Anders Krogh; Elena Papaleo
Journal:  Breast Cancer Res       Date:  2020-06-30       Impact factor: 6.466

8.  Long non-coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer.

Authors:  Junfeng Sun; Jianying Yang; Kui Lv; Jianguo Guan
Journal:  Oncol Lett       Date:  2020-05-20       Impact factor: 2.967

9.  MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).

Authors:  Yong Zhu; Xing Wen; Peng Zhao
Journal:  Med Sci Monit       Date:  2018-06-02

Review 10.  MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.

Authors:  Omid Kooshkaki; Zohre Rezaei; Meysam Rahmati; Parviz Vahedi; Afshin Derakhshani; Oronzo Brunetti; Amir Baghbanzadeh; Behzad Mansoori; Nicola Silvestris; Behzad Baradaran
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.